ARS Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 22.7M | 28.1M | 32.5M | 15.7M | 8.0M | 86.6M | 2.1M | 500K |
| Cost of Goods Sold | 6.3M | 3.2M | 8.2M | 5.0M | 4.0M | 3.9M | 112K | 6.9M |
| Gross Profit | 16.4M | 24.9M | 24.3M | 10.7M | 3.9M | 82.7M | 2.0M | -6.4M |
| R&D Expenses | 4.3M | 3.4M | 2.8M | 4.0M | 3.0M | 3.0M | 4.4M | 6.9M |
| Operating Expenses | 76.5M | 66.3M | 77.5M | 58.3M | 41.1M | 35.5M | 23.7M | 8.9M |
| Operating Income | -60.1M | -41.5M | -53.2M | -47.6M | -37.2M | 47.2M | -21.7M | -15.3M |
| Other Income / Gains | -473K | 61K | 2.0M | 2.7M | 3.2M | 3.0M | 2.6M | 2.8M |
| Net Income | -60.6M | -41.3M | -51.2M | -44.9M | -33.9M | 49.9M | -19.1M | -12.5M |
| EPS (Diluted) | -0.61 | -0.42 | -0.52 | -0.46 | -0.35 | 0.51 | -0.20 | -0.13 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.723 | 0.886 | 0.748 | 0.683 | 0.493 | 0.955 | 0.946 | -12.792 |
| General And Administrative Expenses | 0 | 0 | 0 | 54.3M | 0 | 0 | 19.3M | 8.9M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 72.2M | 60.0M | 74.8M | 54.3M | 0 | 0 | 19.3M | 8.9M |
| Other Expenses | 0 | 3.0M | 0 | 0 | 38.2M | 32.5M | 0 | -6.9M |
| Cost And Expenses | 82.8M | 69.6M | 85.7M | 63.3M | 45.1M | 39.4M | 23.8M | 15.8M |
| Interest Income | 2.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 397K | 417K | 2.4M | 279K | 280K | 29K | 21K | 18K |
| Ebitda | -57.8M | -41.0M | -48.8M | -44.6M | -33.7M | 50.3M | -19.1M | -12.5M |
| Ebitdaratio | -2.548 | -1.459 | -1.501 | -2.838 | -4.222 | 0.58 | -9.239 | -24.996 |
| Operating Income Ratio | -2.652 | -1.476 | -1.637 | -3.029 | -4.663 | 0.545 | -10.516 | -30.68 |
| Income Before Tax | -60.6M | -41.4M | -51.2M | -44.9M | -33.9M | 50.2M | -19.1M | -12.5M |
| Income Before Tax Ratio | -2.673 | -1.474 | -1.574 | -2.856 | -4.257 | 0.58 | -9.25 | -25.032 |
| Income Tax Expense | 0 | -80K | 0 | 0 | 0 | 288K | 0 | 0 |
| Net Income Ratio | -2.673 | -1.471 | -1.574 | -2.856 | -4.257 | 0.577 | -9.25 | -25.032 |
| Epsdiluted | -0.61 | -0.42 | -0.52 | -0.46 | -0.35 | 0.51 | -0.20 | -0.13 |
| Weighted Average Shs Out | 99.3M | 98.6M | 98.8M | 98.4M | 98.1M | 98.0M | 97.0M | 96.8M |
| Weighted Average Shs Out Dil | 99.3M | 98.6M | 98.8M | 98.4M | 98.1M | 98.0M | 97.0M | 96.8M |